DIABETES MELLITUS WITH THE GLY574SER VARIANT OF THE HNF1A GENE ENCODING THE TRASCRIPTION FACTOR HNF-1A

Ngọc Cấn Thị Bích, Khánh Nguyễn Ngọc

Main Article Content

Abstract

Maturity-onset diabetes of the young (MODY) is the most common form of monogenic diabetes, characterized by autosomal dominant inheritance, early onset, and absence of pancreatic autoantibodies. It is a rare condition with clinical features that often overlap with both type 1 and type 2 diabetes. With advances in genetic technology, 14 subtypes have been described, each differing in prevalence, complications, and treatment. Objectives: To describe the relationship between clinical presentation and the g.120999579A>G variant in the HNF1A gene. Subjects: A diabetes case diagnosed and treated at the National Children’s Hospital, Vietnam. Methods: Case report. Results: A 5-year-old obese girl presented with polyuria and polydipsia. Initial capillary blood glucose was 31 mmol/L, HbA1c was 11.6%, and C-peptide was 2.24 ng/mL. Blood gas analysis showed no acidosis, and urine ketones were 1+. Her mother had a history of type 2 diabetes diagnosed during pregnancy at age 33. After identifying the disease-causing genetic variant, the patient was planned for a transition from insulin to oral medication. Conclusion: This case highlights the importance of genetic testing in patients with a family history of diabetes and underlines the challenges in interpreting the clinical significance of genetic variants, particularly when the clinical presentation aligns with a form of monogenic diabetes.

Article Details

References

1. Anık, Ahmet, et al. (2015), "Maturity-onset diabetes of the young (MODY): an update", Journal of pediatric endocrinology & metabolism: JPEM. 28(3-4), pp. 251-263.
2. Balamurugan, K., et al. (2016), "Structure-function studies of HNF1A (MODY3) gene mutations in South Indian patients with monogenic diabetes", Clinical Genetics. 90(6), pp. 486-495.
3. Collet, C., et al. (2002), "Prevalence of the missense mutation Gly574Ser in the hepatocyte nuclear factor-1alpha in Africans with diabetes", Diabetes Metab. 28(1), pp. 39-44.
4. Donald, Tim J., et al. (2012), "Lipoprotein composition in HNF1A-MODY: Differentiating between HNF1A-MODY and Type 2 diabetes", Clinica Chimica Acta. 413(9), pp. 927-932.
5. Firdous, Parveena, et al. (2018), "Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives", Frontiers in Endocrinology. 9, p. 253.
6. Heuvel-Borsboom, H., et al. (2016), "Maturity onset diabetes of the young: Seek and you will find", The Netherlands Journal of Medicine. 74(5), pp. 193-200.
7. Kleinberger, Jeffrey W., et al. (2018), "Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial", Genetics in Medicine: Official Journal of the American College of Medical Genetics. 20(6), pp. 583-590.
8. Libman, Ingrid, et al. (2022), "ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents", Pediatric Diabetes. 23(8), pp. 1160-1174.
9. Mauvais-Jarvis, F., et al. (2003), "The polymorphism Gly574Ser in the transcription factor HNF-1alpha is not a marker of adult-onset ketosis-prone atypical diabetes in Afro-Caribbean patients", Diabetologia. 46(5), pp. 728-9.